Age, genes, sex, and smell: predicting Parkinson disease

Florence Mahoney Lecture on Aging | Wednesday, May 4, 2016 | 3:00 to 4:00 p.m. ET

Andrew Singleton, Ph.D.

NIH Distinguished Investigator

National Institute on Aging

singleta@mail.nih.gov

Website

In 2001 Dr. Singleton joined the NIA as an Investigator within the newly created Laboratory of Neurogenetics. Dr. Singleton’s group investigates the genetic and cellular mechanisms underlying simple-Mendelian and complex neurological diseases.

Summary

Dr. Singleton’s talk will focus on the most effective route to testing disease-modifying therapies in neurodegenerative disease earlier in the disease process, with a particular focus on Parkinson disease. He will discuss attempts to make headway in identifying at-risk patients as early as possible in the disease process, when interventions may be most effective.